Your browser doesn't support javascript.
loading
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance.
Tan, Catherine L; Kuchroo, Juhi R; Sage, Peter T; Liang, Dan; Francisco, Loise M; Buck, Jessica; Thaker, Youg Raj; Zhang, Qianxia; McArdel, Shannon L; Juneja, Vikram R; Lee, Sun Jung; Lovitch, Scott B; Lian, Christine; Murphy, George F; Blazar, Bruce R; Vignali, Dario A A; Freeman, Gordon J; Sharpe, Arlene H.
Afiliación
  • Tan CL; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Kuchroo JR; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Sage PT; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Liang D; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Francisco LM; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Buck J; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Thaker YR; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Zhang Q; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • McArdel SL; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Juneja VR; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Lee SJ; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Lovitch SB; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Lian C; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Murphy GF; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Blazar BR; School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, UK.
  • Vignali DAA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • Freeman GJ; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA.
  • Sharpe AH; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
J Exp Med ; 218(1)2021 01 04.
Article en En | MEDLINE | ID: mdl-33045061
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Linfocitos T Reguladores / Diabetes Mellitus Experimental / Encefalomielitis Autoinmune Experimental / Receptor de Muerte Celular Programada 1 / Tolerancia Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Exp Med Año: 2021 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Linfocitos T Reguladores / Diabetes Mellitus Experimental / Encefalomielitis Autoinmune Experimental / Receptor de Muerte Celular Programada 1 / Tolerancia Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Exp Med Año: 2021 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos